Recommended reading from the beth Israel hospital pulmonary and critical care fellowship program: phillip factor, d.o., program director

Edwin Laryea Annan et al. Am J Respir Crit Care Med. 2011.

. 2011 Aug 1;184(3):379-80.

doi: 10.1164/rccm.201011-1868RR.

No abstract available

Comment on

Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.
Wang C, Zhai Z, Yang Y, Wu Q, Cheng Z, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH; China Venous Thromboembolism (VTE) Study Group. Wang C, et al. Chest. 2010 Feb;137(2):254-62. doi: 10.1378/chest.09-0765. Epub 2009 Sep 9. Chest. 2010. PMID: 19741062 Free PMC article. Clinical Trial.
The relationship between chest tube size and clinical outcome in pleural infection.
Rahman NM, Maskell NA, Davies CW, Hedley EL, Nunn AJ, Gleeson FV, Davies RJ. Rahman NM, et al. Chest. 2010 Mar;137(3):536-43. doi: 10.1378/chest.09-1044. Epub 2009 Oct 9. Chest. 2010. PMID: 19820073 Clinical Trial.
Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial.
Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, Grasso S, Munari M, Boifava S, Cornara G, Della Corte F, Vivaldi N, Malacarne P, Del Gaudio P, Livigni S, Zavala E, Filippini C, Martin EL, Donadio PP, Mastromauro I, Ranieri VM. Mascia L, et al. JAMA. 2010 Dec 15;304(23):2620-7. doi: 10.1001/jama.2010.1796. JAMA. 2010. PMID: 21156950 Clinical Trial.